← FDA Drug Approvals (Drugs@FDA)
SPIRONOLACTONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS · Approved 2010-07-02
Drug application
- FDA Application #
ANDA091426- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SPIRONOLACTONE
- Generic name
- SPIRONOLACTONE
- Active ingredients
- SPIRONOLACTONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AMNEAL PHARMS
- Manufacturer
- Amneal Pharmaceuticals LLC
- First approval
- 2010-07-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown